Skip to navigation Skip to content

News

Share

Harvard Scientist Wins Barancik Prize for Innovation in MS Research

January 28, 2020

--Professor Francisco Quintana to receive 2019 Prize for work toward understanding what triggers multiple sclerosis and how to stop it
 
Francisco J. Quintana, Ph.D., a leading multiple sclerosis researcher at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, Harvard Medical School, is the winner of the 2019 Barancik Prize for Innovation in MS Research.Quintana-official2019.jpg
 
Professor Quintana has established innovative research programs that use advanced technology to make significant contributions to the understanding of the immune response and to identify potential therapeutic targets and biomarkers for MS. He recently developed a new research platform to identify gene-environment interactions that control central nervous system inflammation that drives the damage that occurs in MS. The studies identified novel pathways involved in the regulation of this inflammation. Moreover, these studies map out a novel way to systematically investigate environmental factors in MS and other diseases.
 
“I am deeply honored to be selected for the Barancik Prize, and thank the Award Committee for recognizing our work,” said Prof. Quintana.
 
“Professor Quintana collaborates on a global scale to apply creative approaches to very complex questions about what triggers brain inflammation in multiple sclerosis and to find ways to stop it,” said Bruce Bebo, Ph.D., executive vice president at the National MS Society, which administers the award. “He has earned the Barancik Prize for being highly resourceful in applying advanced technologies to make progress toward developing new treatment approaches, especially for progressive forms of MS.”
 
Prof. Quintana earned a diploma in biology from the University of Buenos Aires and adoctorate in immunology from the Weizmann Institute of Science in Rehovot, Israel. He completed his postdoctoral training at the Weizmann Institute and at Brigham and Women’s Hospital. He is a Professor of Neurology at the Ann Romney Center for Neurologic Diseases, an Associate Member at the Broad Institute of Harvard and MIT, and incoming president of the International Society of Neuroimmunology. His awards are numerous, including Young Investigator Awards in Ireland and Italy, a Pathway to Independence Award from NIAID/NIH, and recipient of a National MS Society Harry Weaver Scholar Award. He has trained more than 30 young investigators, and participates in several programs focused on training scientists from underrepresented minorities.
 
He will receive the award and deliver the Barancik Prize lecture at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum on Feb. 27 in West Palm Beach, Florida.
 
About the Barancik Prize for Innovation in MS Research
The Barancik Prize seeks to recognize and encourage exceptional innovation and originality in scientific research relevant to multiple sclerosis, with emphasis on impact and potential of the research to lead to pathways for the treatment and cure for MS, and scientific accomplishments that merit recognition as a future leader in MS research. The international prize is administered through the National MS Society and made possible by the generosity of the Charles and Margery Barancik Foundation.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.